“A Randomised Single Blind Controlled Trial to Assess Effect of Amalaki (Emblica Officinalis) 30 CH of Type 2 Diabetes Mellitus Taking Conventional Treatment as Add on Therapy : A Pilot Study ”, ahr, vol. 4, no. 4, pp. 43–53, Aug. 2022, Accessed: Apr. 29, 2025. [Online]. Available: https://journals.acspublisher.com/index.php/ahr/article/view/2024